Showing results (51-60 of 226) with videos related to

Sort By:
Pageof 23
Basic & Clinical Pharmacology & Toxicology|October 12, 2023
Drug-related deaths in a university hospital: Comparison to previous decadesMirjam Kauppila, Janne T Backman, Mikko Niemi, et al.
British Journal of Clinical Pharmacology|September 13, 2003
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjectsMikko Niemi, Janne T Backman, Mikko Neuvonen, et al.
European Journal of Clinical Pharmacology|March 3, 2007
Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofenAleksi Tornio, Mikko Niemi, Pertti J Neuvonen, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2016
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transportersAleksi Tornio, Pertti J Neuvonen, Mikko Niemi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2007
Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazoneAleksi Tornio, Mikko Niemi, Pertti J Neuvonen, et al.
European Journal of Clinical Pharmacology|November 14, 2020
Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency departmentMirjam Kauppila, Janne T Backman, Mikko Niemi, et al.
Clinical Pharmacology and Therapeutics|March 31, 2000
Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisoloneT Varis, J T Backman, K T Kivistö, et al.
Clinical Pharmacology and Therapeutics|March 4, 2006
Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinideLauri I Kajosaari, Mikko Niemi, Janne T Backman, et al.
British Journal of Clinical Pharmacology|March 5, 2004
Tizanidine is mainly metabolized by cytochrome p450 1A2 in vitroMarika T Granfors, Janne T Backman, Jouko Laitila, et al.
Pageof 23